Thursday, 18 March 2021
*MSK = Moscow Standard Time
Topics
Meeting category
Date(s)
1 Mar 2021 - 31 May 2021
Important dates
1st Edition
Thursday, 18 March 2021
2nd Edition
Thursday, 15 April 2021
3rd Edition
Thursday, 13 May 2021
Meeting type
Virtual Meeting
Organizer
Russian HIV Clinical Series 2021
Related Enduring Materials
Enduring Materials
1st Edition: Integrase Inhibitors in Clinical Practice
1st Edition: Integrase Inhibitors in Clinical Practice - 10:05
10:05 - 10:25
Reviewing Clinical Trial Data Supporting the Registration of Integrase Inhibitors for Clinical Management
10:25 - 10:45
Position of Integrase Inhibitors in HIV Treatment (International Guidelines)
10:45 - 11:05
Clinical Experiences With Integrase Inhibitors in Russia
2nd Edition: Consideration Choosing Antiretroviral Therapy
Thursday, 15 April 2021
*MSK = Moscow Standard Time
2nd Edition: Consideration Choosing Antiretroviral Therapy - 10:05
Anna Maria Geretti, MD, PhD, FRCPath
10:05 - 10:25
Clinical Consideration Using Integrase Inhibitors (Resistance + Pharmacology)
10:25 - 10:45
Impact of Transmitted Drug Resistance on Treatment Choices
University of Rome, Italy / King's College London, United Kingdom
10:45 - 11:05
Clinical Case Presentation
3rd Edition: Clinical Management of PLWH That Need Additional Considerations
3rd Edition: Clinical Management of PLWH That Need Additional Considerations - 10:00
10:00 - 10:20
Special Populations: Women at Childbearing Age
10:20 - 10:40
Special Populations: Co-Infections
10:40 - 11:00
Clinical Case Presentation
Overview
Image
The Online Russian Series featured lectures on novel treatment strategies. The program was designed to close the most important knowledge gaps in HIV clinical care in Russia and other globally comparable areas. New findings were presented and discussed within the context of Russia, reflecting on the regional and local aspects of the epidemic, national policies, guidelines, and societal context. In addition, clinical cases relevant to Russian healthcare providers were discussed to allow the participants to apply the acquired knowledge to clinical practice.
This Educational Series included 3 individual 90-minute educational activities focused on the most pressing knowledge gaps in Russian HIV healthcare, such as the implementation of novel treatment strategies in the context of viral hepatitis co-infection, drug resistance, plausible metabolic complications, compromised adherence, or aging and onset of comorbidities.
Each activity was delivered as a livestreamed webinar. The meeting language was in Russian. Simultaneous translation was provided during the meeting.
Program Directors
General Information
Meeting Objectives
With the HIV Clinical Forum program we aim to:
- Build a community of healthcare professionals devoted to providing optimal clinical care for their patients;
- Create a platform for interactive information exchange on novel treatment options; and
- Translate the latest research achievements into clinical guidance for the optimal management of individuals living with HIV.
- Build a community of healthcare professionals devoted to providing optimal clinical care for their patients;
- Create a platform for interactive information exchange on novel treatment options; and
- Translate the latest research achievements into clinical guidance for the optimal management of individuals living with HIV.
Learning Objectives
After participating in the HIV Clinical Forum, participants will be able to:
- Understand the clinical data supporting novel treatment strategies;
- Describe the pros and cons of novel treatment strategies;
- Understand how to integrate novel treatment strategies into routine patient care;
- Be knowledgeable of the clinical data supporting long-acting injectable regimens;
- Identify patients who might best benefit from long acting injectable regimens;
- Know how best to integrate injectable drugs in to routine clinical care;
- Improve their skills in defining and identifying complex HIV patients;
- Stay informed on new drug options for complex patients; and
- Understand how best to use new treatment options in complex HIV patients.
- Understand the clinical data supporting novel treatment strategies;
- Describe the pros and cons of novel treatment strategies;
- Understand how to integrate novel treatment strategies into routine patient care;
- Be knowledgeable of the clinical data supporting long-acting injectable regimens;
- Identify patients who might best benefit from long acting injectable regimens;
- Know how best to integrate injectable drugs in to routine clinical care;
- Improve their skills in defining and identifying complex HIV patients;
- Stay informed on new drug options for complex patients; and
- Understand how best to use new treatment options in complex HIV patients.
Practical Information
Disclaimer
This forum meeting is intended for educational purposes only and aims to offer participants the opportunity to share information. The Organizing Secretariat of meeting, Virology Education, cannot accept any liability for the scientific content of the sessions or for any claims which may result from the use of information or publications from the meeting. Virology Education disclaims all liability for injuries or losses of whatever nature incurred by individuals attending this forum meeting.
Language
Simultaneous translation from English to Russian was available throughout the meeting.
Committees
Program Directors
The Program Directors are a group of carefully selected experts and inspirational leaders in their respective fields. They meet frequently to discuss the scientific program of the forum meeting, identify interesting topics and candidate speakers, and review all submitted abstracts.
Support
Поддержка
The Online Russian Series 2021 is supported by an independent educational grant from ViiV Healthcare.
ViiV Healthcare was not involved in the development of content or selection of faculty for this educational activity.
Образовательный партнер
Erasmus MC
NATAP
HBA
Language
